142,957 members

Skip to content. | Skip to navigation

News

NICE draft guidance recommends new treatment option for people with early breast cancer

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NICE draft guidance recommends new treatment option for people with early breast cancer

NICE has published draft guidance which recommends trastuzumab emtansine (also called Kadcyla and made by Roche) as an option for some people with HER2-positive early breast cancer.